Efficacy and Safety of Telaprevir-Based Antiviral Treatment for Elderly Patients with Hepatitis C Virus

Masahiro Takita; Satoru Hagiwara; Masatoshi Kudo; Masashi Kouno; Hirokazu Chishina; Tadaaki Arizumi; Satoshi Kitai; Norihisa Yada; Tatsuo Inoue; Yasunori Minami; Kazuomi Ueshima

doi:10.1159/000368154

Abstract

1 min read

Although the incidence of anemia was higher in group B, there was no significant difference in the treatment completion or SVR24 rate between the groups. Telaprevir combination therapy is suggested to be tolerable for elderly hepatitis C patients.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2016

Safety, Tolerability, and Efficacy of Sofosbuvir Plus Ribavirin in Elderly Patients Infected with Hepatitis C Virus Genotype 2

Naoshi Nishida, Masashi Kono, Tomohiro Minami, Hirokazu Chishina, Tadaaki Arizumi, Masahiro Takita, Norihisa Yada, Hiroshi Ida, Satoru Hagiwara, Yasunori Minami, Kazuomi Ueshima, Tashiharu Sakurai, Masatoshi Kudo

Article2016

Risk of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Who Achieved Sustained Virological Response

Masatoshi Kudo

Article2015

Development of antiviral drugs for the treatment of hepatitis C at an accelerating pace

De Clercq Erik

Article2010

Antiviral Treatment of Chronic Hepatitis B Virus (HBV) Infections

De Clercq Erik, Geoffrey Férir, Suzanne J. F. Kaptein, Johan Neyts

Article1996

Low dose alpha interferon therapy can be effective in chronic active hepatitis C. Results of a multicentre, randomised trial.

J.M. Sánchez‐Tapias, Xavier Forns, Sergi Ampurdanés, Lluçia Titó, Ramón Planas, J.M. Viver, D Acero, Maribel Rodríguez Torres, P. Más, Rosa M. Morillas, M. Forné, J. Espinós, Josep M. Llovet, J. Costa, Eva María Olmedo Moreno, F. Xavier López‐Labrador, M. T. Jiménez de Anta, J Rodés

Gut